A new B-Raf inhibitor combo for advanced melanoma

Oncotarget. 2018 Oct 2;9(77):34457-34458. doi: 10.18632/oncotarget.26171.

Authors

Marjam-Jeanette Barysch¹, Joanna Mangana¹, Reinhard Dummer¹

Affiliation

¹ Reinhard Dummer: Department of Dermatology, University Hospital Zurich, Switzerland; University of Zurich, Zurich, Switzerland.

No abstract available

Keywords: BRAF/MEK inhibition; COLUMBUS; binimetinib; encorafenib; melanoma.

Publication types

Editorial